Effect of losartan and benzbromarone on the level of human urate transporter 1 mRNA

Yora Nindita; Toshihiro Hamada; Udin Bahrudin; Makoto Hosoyamada; Kimiyoshi Ichida; Chisato Iwai; Sunao Urashima; Masanari Kuwabara; Sulistiyati Bayu Utami; Einosuke Mizuta; Kensaku Yamada; Osamu Igawa; Chiaki Shigemasa; Haruaki Ninomiya; Takuya Tsuchihashi; Ichiro Hisatome

doi:10.1055/s-0033-1363730

Drug Research, Inhaltsverzeichnis

Arzneimittelforschung 2014; 64(02): 103
DOI: 10.1055/s-0033-1363730

Erratum

Effect of losartan and benzbromarone on the level of human urate transporter 1 mRNA

Autoren

Yora Nindita

¹Division of Regenerative Medicine and Therapeutics, Department of Genetic Medicine and Regenerative Therapeutics, Institute of Regenerative Medicine and Biofunction, Tottori University Graduate School of Medical Science, Yonago, Japan

²Department of Pharmacology and Therapeutics, Faculty of Medicine, Diponegoro University, Semarang, Indonesia
Toshihiro Hamada

³Department of Cardiovascular Medicine, Tottori University Faculty of Medicine Yonago, Japan
Udin Bahrudin

¹Division of Regenerative Medicine and Therapeutics, Department of Genetic Medicine and Regenerative Therapeutics, Institute of Regenerative Medicine and Biofunction, Tottori University Graduate School of Medical Science, Yonago, Japan

⁴Department of Cardiology and Vascular Medicine, Faculty of Medicine, Diponegoro University, Semarang, Indonesia
Makoto Hosoyamada

⁵Department of Pharmacotherapeutics, Kyoritsy University of Pharmacy, Tokyo, Japan
Kimiyoshi Ichida

⁶Department of Pathophysiology, Tokyo University of Pharmacy and Life Science, Tokyo, Japan
Chisato Iwai

¹Division of Regenerative Medicine and Therapeutics, Department of Genetic Medicine and Regenerative Therapeutics, Institute of Regenerative Medicine and Biofunction, Tottori University Graduate School of Medical Science, Yonago, Japan
Sunao Urashima

¹Division of Regenerative Medicine and Therapeutics, Department of Genetic Medicine and Regenerative Therapeutics, Institute of Regenerative Medicine and Biofunction, Tottori University Graduate School of Medical Science, Yonago, Japan
Masanari Kuwabara

¹Division of Regenerative Medicine and Therapeutics, Department of Genetic Medicine and Regenerative Therapeutics, Institute of Regenerative Medicine and Biofunction, Tottori University Graduate School of Medical Science, Yonago, Japan
Sulistiyati Bayu Utami

¹Division of Regenerative Medicine and Therapeutics, Department of Genetic Medicine and Regenerative Therapeutics, Institute of Regenerative Medicine and Biofunction, Tottori University Graduate School of Medical Science, Yonago, Japan
Einosuke Mizuta

³Department of Cardiovascular Medicine, Tottori University Faculty of Medicine Yonago, Japan
Kensaku Yamada

³Department of Cardiovascular Medicine, Tottori University Faculty of Medicine Yonago, Japan
Osamu Igawa

³Department of Cardiovascular Medicine, Tottori University Faculty of Medicine Yonago, Japan
Chiaki Shigemasa

³Department of Cardiovascular Medicine, Tottori University Faculty of Medicine Yonago, Japan
Haruaki Ninomiya

⁷Department of Biological Regulation, Tottori University Faculty of Medicine Yonago, Japan
Takuya Tsuchihashi

⁸Division of Hypertension, Clinical Research Center, National Kyushu Medical Center, Fukuoka, Japan
Ichiro Hisatome

¹Division of Regenerative Medicine and Therapeutics, Department of Genetic Medicine and Regenerative Therapeutics, Institute of Regenerative Medicine and Biofunction, Tottori University Graduate School of Medical Science, Yonago, Japan